Editorial Lymphangiogenesis A Potential New Therapy for Lymphedema ?
نویسنده
چکیده
At the level of the capillaries, the systemic circulation loses 2 to 4 L fluid and 100 g protein into the interstitium daily. This ultrafiltrate of the systemic capillaries is returned to the circulatory system by the lymphatics. The lymphatic vasculature is highly specialized to perform this service, beginning with the blind-ended lymphatic capillaries. These vessels are highly permeable to protein, fluid, and even cells because of fenestrations in their basement membrane and discontinuous button-like junctions rather than tight intercellular junctions, as observed in the systemic capillaries.1 The lymphatic capillaries merge into collectors and larger lymphatic conduits that are invested with vascular smooth muscle (capable of contracting and propelling lymph forward) and valves for unidirectional flow. These conduits merge at lymph nodes, delivering antigens to the immune cells and serving as an early warning system of pathogen invasion. The lymph nodes drain into conduits that ultimately merge into the thoracic duct, which empties into the left subclavian vein.
منابع مشابه
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
Although lymphedema is a common clinical condition, treatment for this disabling condition remains limited and largely ineffective. Recently, it has been reported that overexpression of VEGF-C correlates with increased lymphatic vessel growth (lymphangiogenesis). However, the effect of VEGF-C-induced lymphangiogenesis on lymphedema has yet to be demonstrated. Here we investigated the impact of ...
متن کاملLymphedema and Therapeutic Lymphangiogenesis
Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return and swelling of the extremities. Lymphedema is divided into primary and secondary forms based on the underlying etiology. Despite substantial advances in both surgical and conservative techniques, therapeutic options for the management of lymphedema are limited. Although rarely lethal, lymphedem...
متن کاملVEGFR-3 in primary lymphedema
...............................................................................................................4 REVIEW OF THE LITERATURE ..............................................................................5 1 Development of the circulatory system.............................................................5 1.1 Vasculogenesis and angiogenesis ............................................
متن کاملLymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
Recent work from many laboratories has demonstrated that the vascular endothelial growth factor-C/VEGF-D/VEGFR-3 signaling pathway is crucial for lymphangiogenesis, and that mutations of the Vegfr3 gene are associated with hereditary lymphedema. Furthermore, VEGF-C gene transfer to the skin of mice with lymphedema induced a regeneration of the cutaneous lymphatic vessel network. However, as is ...
متن کامل